Bi Asset Management Fondsmaeglerselskab A Exelixis, Inc. Transaction History

Bi Asset Management Fondsmaeglerselskab A

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$18.39 - $24.8 $687,602 - $927,272	-37,390 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$16.46 - $27.42 $587,375 - $978,482	-35,685 Reduced 48.83%	37,390 $888,000
Q1 2020 May 11, 2020	SELL	$14.46 - $21.8 $2.63 Million - $3.96 Million	-181,681 Reduced 71.32%	73,075 $1.26 Million
Q4 2019 Mar 19, 2020	BUY	$15.15 - $18.89 $3.86 Million - $4.81 Million	254,756 New	254,756 $4.49 Million

460

240M

2.04M

1.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $8.35B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.